西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2014年
4期
100-101
,共2页
子宫内膜异位症%复方莪术散%米非司酮%孕三烯酮%辅助治疗%术后
子宮內膜異位癥%複方莪術散%米非司酮%孕三烯酮%輔助治療%術後
자궁내막이위증%복방아술산%미비사동%잉삼희동%보조치료%술후
endometriosis%compound EZhu powder%mifepristone%gestrinone%adjunctive therapy%postoperative
目的：探讨中药复方莪术散用于子宫内膜异位症术后辅助治疗的临床疗效。方法：将92例患者随机分为3组。复方莪术散组（32例）术后7天开始服用复方莪术散,开水冲药液200 mL,1次/d，口服,经期不停药；米非司酮治疗组（30例）于术后7天开始服用米非司酮,10 mg/次,1次/d；孕三烯酮治疗组（30例）于术后7天开始服用孕三烯酮,2.5 mg/次,每周2次。3组疗程均为6个月。比较3组临床疗效、妊娠情况及不良反应。结果：复方莪术散组总有效率为96.9%，复发率为3.1%；米非司酮组与孕三烯酮组总有效率均为96.67%，复发率均为3.33%。术后妊娠率复方莪术散组为60%，米非司酮组为28.6%，孕三烯酮组为25%。复方莪术散不良反应少且症状轻微。结论：复方莪术散用于子宫内膜异位症术后可提高临床疗效及受孕率，且副反应小。
目的：探討中藥複方莪術散用于子宮內膜異位癥術後輔助治療的臨床療效。方法：將92例患者隨機分為3組。複方莪術散組（32例）術後7天開始服用複方莪術散,開水遲藥液200 mL,1次/d，口服,經期不停藥；米非司酮治療組（30例）于術後7天開始服用米非司酮,10 mg/次,1次/d；孕三烯酮治療組（30例）于術後7天開始服用孕三烯酮,2.5 mg/次,每週2次。3組療程均為6箇月。比較3組臨床療效、妊娠情況及不良反應。結果：複方莪術散組總有效率為96.9%，複髮率為3.1%；米非司酮組與孕三烯酮組總有效率均為96.67%，複髮率均為3.33%。術後妊娠率複方莪術散組為60%，米非司酮組為28.6%，孕三烯酮組為25%。複方莪術散不良反應少且癥狀輕微。結論：複方莪術散用于子宮內膜異位癥術後可提高臨床療效及受孕率，且副反應小。
목적：탐토중약복방아술산용우자궁내막이위증술후보조치료적림상료효。방법：장92례환자수궤분위3조。복방아술산조（32례）술후7천개시복용복방아술산,개수충약액200 mL,1차/d，구복,경기불정약；미비사동치료조（30례）우술후7천개시복용미비사동,10 mg/차,1차/d；잉삼희동치료조（30례）우술후7천개시복용잉삼희동,2.5 mg/차,매주2차。3조료정균위6개월。비교3조림상료효、임신정황급불량반응。결과：복방아술산조총유효솔위96.9%，복발솔위3.1%；미비사동조여잉삼희동조총유효솔균위96.67%，복발솔균위3.33%。술후임신솔복방아술산조위60%，미비사동조위28.6%，잉삼희동조위25%。복방아술산불량반응소차증상경미。결론：복방아술산용우자궁내막이위증술후가제고림상료효급수잉솔，차부반응소。
Objective:To explore clinical value of compound EZhu powder in the adjunctive therapy for the patients after the operation of endometriosis. Methods:Ninety-two patients were divided to three groups. Compound EZhu powder group (32 cases) took the medicine in seven days after the surgery orally, dissolved the solution (200 mL) with boiling water, once per day, the patients continued to take the medicine in the period;the treatment group of mifepristone(30 cases) were given with the drugs in seven days after the surgery, 10 mg each time, once per day;the treatment group of gestrinone (30 cases) accepted the drugs in seven days after the surgery, 2.5 mg each time, twice per week. One course of the treatment was six months. Curative effects, the conditions of pregnancy and adverse reactions of three groups were compared. Results:Total effective rate and recurrent rate of compound EZhu powder group were 96.9% and 3.1%; while the rates of the other two groups were 96.67% and 3.33%. Postoperative pregnancy rate of compound EZhu powder group was 60%, higher than 28.6% of the treatment group of mifepristone and 25%of the treatment group of gestrinone. Compound EZhu powder was with minor adverse reaction. Conclusion:Compound EZhu powder for the patients after the operation of endometriosis could improve therapeutic effects and pregnancy rate with minor adverse reaction.
